WHO Should Include TB On List Of Priority Drug-Resistant Pathogens

Live Science: Tuberculosis Needs More Recognition As a Worldwide Health Threat
Deliana Garcia director of international relations, research, and development for the Migrant Clinicians Network

“…Here are four reasons TB should hold the No. 1 spot on the WHO’s [priority pathogens] list: 1. TB is the No. 1 infectious-disease killer on the planet, surpassing HIV/AIDS. … 2. It’s inexpensive to cure TB. Yet, we can’t manage to stamp it out. … 3. Drug-resistant TB is on the rise, and it’s deadly. 4. Doctors continue to rely on 110-year-old skin tests to diagnose TB, because funding dedicated to finding easier, quicker, and cheaper methods has stagnated. … TB should already be wiped off the planet, but we lack the political will and funding focus to deliver it a death blow. Instead, public health officials continue to make major missteps, like leaving it off of the WHO list of antibiotic-resistant bacteria, when it should be center stage. … Leaving TB off this list makes it appear that it is less critical than the other bacteria listed — and gives the dangerous impression that TB is under control. We urge the WHO to include drug-resistant TB on its list, because new lines of defense are urgently needed to head off this surge of drug-resistant TB” (3/31).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.